Revisão Revisado por pares

Impact of a Telemedicine Program After a Heart Failure Hospitalization on 12 Months Follow-Up Events

2023; Elsevier BV; Volume: 48; Issue: 6 Linguagem: Inglês

10.1016/j.cpcardiol.2023.101624

ISSN

1535-6280

Autores

María Inés Sosa Liprandi, Melisa Elfman, Ezequiel Zaidel, Matías Viniegra, Álvaro Sosa Liprandi,

Tópico(s)

Cardiac Health and Mental Health

Resumo

The aim of this study was to describe the safety, effectiveness, and usability of a mobile-app based follow up platform after a heart failure (HF) hospitalization. It was a pilot, prospective implementation study. 55 consecutive patients were included. Over 12 months, a significant increase in the use of renin angiotensin system inhibitors was observed (91% vs 76%, P < 0.04). Medication adherence, assessed by daily patient validation in the app was 96%. No relevant changes were found in biochemical evaluations. The parameters of app usability showed a high value. At 12 months follow-up one patient was hospitalized for HF (1/55 [1,8%]), there was no cardiovascular death, and 5 patients had non-cardiovascular deaths (5/55 [9.1%]). In patients recently discharged from HF hospitalization, the implementation of non-invasive telemedicine follow-up was feasible, safe and an effective strategy to increase the adherence to medical therapy. A high degree of clinical stability and a low rate of events were observed over 1-year.

Referência(s)